Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Z. K. Salpagarova"'
Publikováno v:
Сеченовский вестник, Vol 0, Iss 2, Pp 8-12 (2022)
The aim of the study was to evaluate efficiency anticoagulant therapy control in primary healthcare setting. The prospective, controlled study involved 301 patients with «non-valvular» atrial fibrillation, receiving various anticoagulant drugs in
Externí odkaz:
https://doaj.org/article/40bcc49a9ee14352a706716b30583dae
Autor:
A. I. Novikova, M. G. Poltavskaya, M. G. Pavlova, P. Sh. Chomakhidze, V. M. Sotnikov, N. A. Potemkina, A. A. Bykova, Z. K. Salpagarova, Z. Z. Fashafsha, T. V. Soboleva, O. V. Andreeva, O. G. Zheludkova, D. А. Andreev
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 11 (2022)
Aim. To study the traditional risk factors for cardiovascular disease (CVD), indicators of endothelial function and exercise tolerance in patients received complex treatment for cranial and craniospinal tumors in childhood, including radiation therap
Externí odkaz:
https://doaj.org/article/1681b9ef52894ac198adaffa28dc5570
Autor:
N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 186-192 (2021)
Atrial fibrillation (AF) is the most frequent type of supraventricular arrhythmias. The anticoagulant therapy should be prescribed to prevent thromboembolic events. According to randomized clinical trials, anticoagulants do not always prove their hig
Externí odkaz:
https://doaj.org/article/7a156dd2338d47919b3f95e4d2e652dc
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 5 (2021)
Catheter ablation (CA) of atrial fibrillation and flutter is associated with a high risk of both perioperative thromboembolic events and bleeding. Adequate anticoagulation is imperative to reduce the risk of complications. The aim of this review was
Externí odkaz:
https://doaj.org/article/6fb85bb890314fcda1a3b776163ccd53
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 7, Iss 1, Pp 80-86 (2015)
The paper considers the main causes and pathogenetic, clinical, and therapeutic aspects of cardioembolic stroke (CES). The latter is emphasized to be a group of conditions, which is highly heterogeneous in its etiology, pathogenesis, course, and prog
Externí odkaz:
https://doaj.org/article/ec8a379d8f4548eb905b87e7b4df3ba5
Autor:
Denis Andreev, А. S. Yadykina, Z. A. Alimova, M I Chashkina, A A Bykova, N. A. Novikova, N. A. Babakova, Z K Salpagarova, D. F. Mesitskaya
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 2, Pp 186-192 (2021)
Atrial fibrillation (AF) is the most frequent type of supraventricular arrhythmias. The anticoagulant therapy should be prescribed to prevent thromboembolic events. According to randomized clinical trials, anticoagulants do not always prove their hig
Autor:
Abram Syrkin, A A Bykova, S A Suchkova, M I Chashkina, A Yu Suvorov, Z K Salpagarova, Denis Andreev, N L Kozlovskaya
Publikováno v:
Kardiologiia. 60:94-100
Aim To evaluate safety of using rivaroxaban in patients with stage 4 chronic kidney disease (CKD) or transient, stable decline of glomerular filtration rate (GFR) to 15–29 ml /min / 1.73 m2 in the presence of atrial fibrillation (AF).Material and m
Autor:
N A Ananicheva, Abram Syrkin, N L Kozlovskaya, A A Bykova, M I Chashkina, Denis Andreev, Z K Salpagarova
Publikováno v:
Kardiologiia. 60:41-46
Objective.To estimate the prevalence of chronic kidney disease (CKD) 3b – 5 stages and the newly diagnosed sustained reduction in glomerular filtration rate (GFR) Materials and Methods. Retrospectively, data of all discharge epicrisis from cardiolo
Autor:
O. A. Baturina, Abram Syrkin, M I Chashkina, N L Kozlovskaya, A A Bykova, Z K Salpagarova, Denis Andreev, A.I. Osipova, A.Y Suvorov
Publikováno v:
European Heart Journal. 41
Background Atrial fibrillation (AF) is a common comorbidity in around 10–15% of patients (pts) with CKD, while 30% of those with AF have CKD. In pts with advanced stages of CKD, safety and efficacy profiles of novel oral anticoagulants, in particul
Autor:
A. A. Bykova, A.I. Osipova, A. Yu. Kuchina, N.V. Vorontsov, A. Yu. Suvorov, Z K Salpagarova, N. A. Novikova
Publikováno v:
Kardiologiya i serdechno-sosudistaya khirurgiya. 14:392